Zobrazeno 1 - 10
of 23
pro vyhledávání: '"T R E, Barnes"'
Publikováno v:
Behavioural Neurology, Vol 6, Iss 1, Pp 49-54 (1993)
A battery of tests for dyspraxia and agnosia was administered to 51 chronic schizophrenic patients to test the hypothesis that these cortical neurological signs are associated with psychomotor poverty syndrome (poverty of speech, flat affect, decreas
Externí odkaz:
https://doaj.org/article/d2f53a5739ac47b98edccb5c9f74d622
Publikováno v:
Psychological medicine. 43(10)
Autor:
T. R. E. Barnes, W. Wolfgang Fleischhacker, J. Beck, A. Hertkorn, S. Heylen, B. Aufdembrinke, P. Bailey, L. Farrow, G. Wegener, Hans-Jürgen Möller, A. Rappard, M. Sloth Nielsen, V. Pedersen, J. P. Leonard, W. Rein, Wolfgang Maier, K. Grafford, R. D. Stieglitz, J. Ryan, H. M. van Praag, John Wilson, H. Bentsen, F. X. Eich, B. Hentschel, J Gerlach, Peter J. McKenna, Y. Lecrubier
Publikováno v:
Psychopharmacology. 115:221-228
There is little agreement about the methodology of clinical trials of antipsychotic drugs in patients with negative symptoms. A literature review revealed wide variation in experimental design, rating scales and study duration. This reflects differin
Publikováno v:
Acta Psychiatrica Scandinavica. 88:243-247
A study of the relationships between depression and the subjective experience of psychological deficits was carried out in a group of 50 schizophrenic patients selected from a population of long-term mentally ill patients. Experience of psychological
Publikováno v:
Acta psychiatrica Scandinavica. 108(6)
Little is known about factors that mediate adherence with medication during the early stages of antipsychotic treatment in schizophrenia. This study sought to identify factors that may be associated with medication adherence in first-episode schizoph
Autor:
T. R. E. Barnes, C. J. B. Mcevedy
Publikováno v:
International clinical psychopharmacology. 11
The care of people with schizophrenia that has failed to respond to conventional antipsychotic medication remains a formidable challenge. However, the introduction of clozapine heralded a new optimism in this area, and prompted an increase in researc
Autor:
T. R. E. Barnes, J. Gerlach
Publikováno v:
Psychopharmacology. 121(3)
Publikováno v:
Psychopharmacology. 121(3)
Six psychotic patients were included in a four-week study of the effects of the D1 selective antagonist SCH 39166 given as monotherapy. Four had a diagnosis of schizophrenia, and two suffered from a schizoaffective disorder. All presented with an acu
Autor:
P R Maycox, F Kelly, A Taylor, S Bates, J Reid, R Logendra, M R Barnes, C Larminie, N Jones, M Lennon, C Davies, J J Hagan, C A Scorer, C Angelinetta, T Akbar, S Hirsch, A M Mortimer, T R E Barnes, J de Belleroche
Publikováno v:
Molecular Psychiatry. 14:1146-1146
Autor:
D. A. W. Johnson, B. Woggon, J. Tegeler, S. R. Marder, T. R. E. Barnes, J. M. Kane, B. Wistedt, F. Müller-Spahn, M. J. Goldstein, W. Kissling, W. W. Fleischhacker, S. J. Dencker
Publikováno v:
Guidelines for Neuroleptic Relapse Prevention in Schizophrenia ISBN: 9783540539858
With the introduction of neuroleptics almost 40 years ago medication became available that had demonstrable efficacy in the prevention of relapse in stabilized schizophrenic patients (Davis 1980; Kane and Lieberman 1987). Nevertheless, the course of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9370cd4213eefc70282199ed309fb2a
https://doi.org/10.1007/978-3-642-86922-8_19
https://doi.org/10.1007/978-3-642-86922-8_19